Neha Sharma, MD
Radiation Oncology · New Port Richey, FLNPI 1750541892
Payments from drug & device makers
Across 101 payments — averaging $34.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$575
- Johnson & Johnson$383
- Pacira Pharmaceuticals Incorporated$320
- Dr.reddy's Laboratories,inc.$287
- Tersera Therapeutics LLC$267
- Cepheid$242
- plus $1K from 30 others
What the payments were for
- Consulting fees$1,32138%
- Speaking & faculty fees$3209%
- Food & beverage$1,79352%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 4 | $575 |
| Johnson & Johnson | 18 | $383 |
| Pacira Pharmaceuticals Incorporated | 1 | $320 |
| Dr.reddy's Laboratories,inc. | 1 | $287 |
| Tersera Therapeutics LLC | 1 | $267 |
| Cepheid | 1 | $242 |
| Sanofi | 8 | $139 |
| Amgen | 8 | $124 |
| Xeris Pharmaceuticals, Inc. | 1 | $119 |
| Daiichi Sankyo Inc. | 5 | $97 |
| Seagen Inc. | 6 | $87 |
| Blueprint Medicines Corporation | 5 | $67 |
| AbbVie | 2 | $60 |
| Puma Biotechnology, Inc. | 4 | $58 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $51 |
| Novartis | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| GSK | 3 | $47 |
| Epizyme, Inc. | 3 | $44 |
| Kyowa Kirin, Inc. | 3 | $41 |
| Pharmaessentia USA Corporation | 2 | $37 |
| Bayer | 2 | $29 |
| Servier Pharmaceuticals LLC | 2 | $29 |
| Incyte Corporation | 1 | $27 |
| Rigel Pharmaceuticals, Inc. | 2 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Eisai Inc. | 1 | $23 |
| UCB, Inc. | 1 | $20 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| AVEO Pharmaceuticals, Inc. | 1 | $15 |
| Deciphera Pharmaceuticals Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TAGRISSO$525
- EXPAREL$320
- GENEXPERT$242
- GVOKE HYPOPEN$119
How this compares
$3,434 in reported general payments places this provider in the 70th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 13 | $157 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in New Port Richey
- Charles KunosMiami$3.2M
- Rupesh KotechaMiami$2M
- Alexander EngelmanTampa$1.1M
- John SylvesterLakewood Ranch$999K
- Kamran AhmedTampa$975K
- Michael ChuongMiami$868K
- Tithi BiswasGainesville$640K
- Daniel TrifilettiJacksonville$606K
- Marcus BredelMiami$578K
- Kathryn HitchcockGainesville$504K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.